Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Type D (delta) hepatitis.

J H Hoofnagle1

  • 1Liver Diseases Section, National Institutes of Health, Bethesda, MD 20892.

JAMA
|March 3, 1989
PubMed
Summary
This summary is machine-generated.

Hepatitis delta virus (HDV) research has advanced understanding of its biology and disease. New cloning and animal models offer hope for better prevention and treatment of this severe liver disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical and metabolic effects associated with weight changes and obeticholic acid in non-alcoholic steatohepatitis.

Alimentary pharmacology & therapeutics·2018
Same author

Complications of percutaneous liver biopsy with Klatskin needles: a 36-year single-centre experience.

Alimentary pharmacology & therapeutics·2017
Same author

Determination of hepatitis B phenotype using biochemical and serological markers.

Journal of viral hepatitis·2016
Same author

Noninvasive markers for staging fibrosis in chronic delta hepatitis.

Alimentary pharmacology & therapeutics·2016
Same author

Long-term lamivudine therapy in chronic hepatitis B.

Alimentary pharmacology & therapeutics·2016
Same author

Liver injury is associated with mortality in sickle cell disease.

Alimentary pharmacology & therapeutics·2015
Same journal

Deescalation, Discontinuation, and Deimplementation Trials: Evaluating Whether and How to Do Less.

JAMA·2026
Same journal

Surgical and Endoscopic Therapies for GERD.

JAMA·2026
Same journal

The Psychedelic Therapies Executive Order: On Approval and Clinical Readiness.

JAMA·2026
Same journal

"Suturing": Love, Death, and Perfection's Limits.

JAMA·2026
Same journal

What Is Low Back Pain?

JAMA·2026
Same journal

From Silicon Valley to the Vatican-The Expanding Debate on AI Ethics.

JAMA·2026
See all related articles

Area of Science:

  • Hepatology
  • Virology
  • Molecular Biology

Background:

  • Hepatitis delta virus (HDV) is a unique RNA virus that requires the hepatitis B virus (HBV) surface antigen for its replication and infectivity.
  • HDV infection leads to a more severe form of viral hepatitis, often resulting in rapid progression to cirrhosis and hepatocellular carcinoma.

Observation:

  • Significant progress has been made in understanding HDV's structure, genome, replication, and epidemiology over the past decade.
  • Recent scientific breakthroughs include the successful cloning of the HDV genome and the establishment of relevant animal models for experimental studies.

Findings:

  • Cloning the HDV genome has facilitated in-depth molecular analyses of its replication strategy.
  • Development of animal models allows for in vivo investigation of HDV pathogenesis and the efficacy of potential therapeutics.

Related Experiment Videos

Implications:

  • These advances provide a foundation for developing novel antiviral strategies against HDV.
  • Improved understanding and experimental models are crucial for advancing the prevention and therapy of HDV-associated liver disease.